Journal article
Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study
S Licata, H Butzkueven, D Jeffery, DL Arnold, M Filippi, JJG Geurts, Q Dong, N Campbell, PR Ho
Journal of the Neurological Sciences | Elsevier BV | Published : 2017